NPL and Jellagen have published breakthrough data demonstrating the potential of collagen derived from jellyfish to support next-generation research and medical applications. New research by the...
Cell and gene therapies are advancing at a rapid rate, but huge costs and time-consuming manual manufacturing processes are keeping therapies out of reach for most...
LiliumX, an innovative BioTech start-up focused on the development of next generation antibody-based therapeutics, has unveiled its new brand name and welcomed three top industry leaders...
Co-founder of investment firm LongeVC, Sergey Jakimov, spoke to Health Tech World about where he sees the most potential in the market and the value of...
By Robert Poolman, SVP Product, Clarivate
By Future Planet Capital Executive Chairman, Douglas Hansen-Luke
By Kellyann Zuzulo, Founder and CEO, Em-Press Media
Alchemab Therapeutics has been awarded a grant of £1.7 million from Innovate UK’s Biomedical Catalyst 2022 funding competition to accelerate development of a first-in-class therapy for...
Prilenia Therapeutics B.V. has announced the appointment of Anne Sullivan as Chief Business Officer. Sullivan will lead all strategic collaboration activities at the clinical stage biotechnology...
Clinical stage biopharmaceutical company BerGenBio has announced the appointment of Cristina Oliva as Chief Medical Officer. Oliva will head up clinical development of the BerGenBio’s selective...
